Rice and Baylor receive $2.8 million to suppress inflammation and lung damage in ARDS patients

Rice University and Baylor College of Medicine have received $2.8 million in funding from the National Heart, Lung, and Blood Institute (NHLBI), a division of the National Institutes of Health (NIH), for research on reducing inflammation and lung damage in acute respiratory distress syndrome (ARDS) patients.

Does drinking coffee during pregnancy really affect a child’s neurodevelopment? New study says likely not

Whether coffee consumption by the mother during pregnancy has an impact on the neurodevelopment of the fetus and could be linked to neurodevelopmental difficulties in

October 14, 2024

Biogen offers to buy out struggling neuro partner Sage Therapeutics

Biogen has made an offer to acquire its partner Sage Therapeutics, according to a Friday evening regulatory disclosure, following months of setbacks by the smaller

January 11, 2025

Acelyrin’s founding CEO steps down, company scraps earnings call

Shao-Lee Lin is stepping down as founding CEO of Acelyrin, a California drug developer that raised the largest biotech IPO in 2023 and subsequently ran

May 10, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.

​​​​​​​Rice and Baylor receive $2.8 million to suppress inflammation and lung damage in ARDS patients